Tranexamic acid in traumatic brain injury: an explanatory study nested within the CRASH-3 trial

PURPOSE: The CRASH-3 trial is a randomised trial of tranexamic acid (TXA) on death and disability in patients with traumatic brain injury (TBI). It is based on the hypothesis that early TXA treatment can prevent deaths from post-traumatic intracranial bleeding. The results showed that timely TXA tre...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851008/
https://www.ncbi.nlm.nih.gov/pubmed/32076783
http://dx.doi.org/10.1007/s00068-020-01316-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851008/
https://www.ncbi.nlm.nih.gov/pubmed/32076783
http://dx.doi.org/10.1007/s00068-020-01316-1

Ejemplares similares